1cBio Received Shareholder Proceeds Upon Closing of BioMarin Pharmaceutical Inc.’s Acquisition of Alesta Therapeutics – PR Newswire
1cBio Received Shareholder Proceeds Upon Closing of BioMarin Pharmaceutical Inc.'s buyout of Alesta Therapeutics PR Newswire Source: news.google.com